Shilajit versus placebo in the management of patients with moderate coronavirus disease 2019: A triple-blind randomized controlled trial protocol

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 946a28711ad5fa05-LAX IP: 47.97.18.252 UTC time: 2025-05-28T02:00:22+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4